Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lasagna

Showing results (11-20 of 199) with videos related to

Pageof 20
Sort By:
Ciba Foundation Symposium|January 1, 1979
Drug concentrations in neuropsychiatry. Introduction: the rational use of plasma drug levels in clinical medicineL Lasagna
European Journal of Rheumatology and Inflammation|January 1, 1993
Macrocyclic molecules and their pharmacological applicationsL Lasagna
Science (New York, N.Y.)|September 8, 1978
Drug regulationL Lasagna
Seminars in Psychiatry|August 1, 1972
The impact of scientific models on clinical psychopharmacology: a pharmacologist's viewL Lasagna
Annals of the New York Academy of Sciences|January 21, 1970
Drug evaluation problems in academic and other contextsL Lasagna
Journal of Clinical Epidemiology|January 1, 1990
Are drug benefits also part of pharmacoepidemiology?L Lasagna
British Journal of Clinical Pharmacology|June 1, 1987
The Lilly Prize lecture. University of London, December 1986. On assuring pharmacotherapeutic progress in the 21st centuryL Lasagna
The New England Journal of Medicine|August 2, 1973
Fault and defaultL Lasagna
The New England Journal of Medicine|November 4, 1976
Randomized clinical trialsL Lasagna
Psychopharmacology Bulletin|April 1, 1972
Constraints on innovation in drug development and useL Lasagna
Pageof 20

Showing results (11-20 of 199) with videos related to

Sort By:
Pageof 20
Ciba Foundation Symposium|January 1, 1979
Drug concentrations in neuropsychiatry. Introduction: the rational use of plasma drug levels in clinical medicineL Lasagna
European Journal of Rheumatology and Inflammation|January 1, 1993
Macrocyclic molecules and their pharmacological applicationsL Lasagna
Science (New York, N.Y.)|September 8, 1978
Drug regulationL Lasagna
Seminars in Psychiatry|August 1, 1972
The impact of scientific models on clinical psychopharmacology: a pharmacologist's viewL Lasagna
Annals of the New York Academy of Sciences|January 21, 1970
Drug evaluation problems in academic and other contextsL Lasagna
Journal of Clinical Epidemiology|January 1, 1990
Are drug benefits also part of pharmacoepidemiology?L Lasagna
British Journal of Clinical Pharmacology|June 1, 1987
The Lilly Prize lecture. University of London, December 1986. On assuring pharmacotherapeutic progress in the 21st centuryL Lasagna
The New England Journal of Medicine|August 2, 1973
Fault and defaultL Lasagna
The New England Journal of Medicine|November 4, 1976
Randomized clinical trialsL Lasagna
Psychopharmacology Bulletin|April 1, 1972
Constraints on innovation in drug development and useL Lasagna
Pageof 20